Effect of Traditional Chinese Medicine on Outcomes in Patients With Mild/Moderate Chronic Obstructive Pulmonary Disease

• Status: Unknown status
• Trial end date: 2014-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is evaluate the effects and safety of Traditional Chinese medicine for prevention and management of mild/moderate chronic obstructive pulmonary disease (COPD).

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Henan University of Traditional Chinese Medicine

Criteria

Inclusion Criteria:

• A confirmed diagnosis of mild/moderate COPD.

• Age between 40 and 80 years.

• Syndrome differentiation belongs to Syndrome of lung-qi deficiency, Syndrome of deficiency of pulmonosplenic qi, Syndrome of insufficiency of QI of the lung and kidney.

• Without participation in other interventional trials in the previous one month.

• With the informed consent signed.

Exclusion Criteria:

• Pregnant or breast-feeding women.

• Any psychiatric condition rendering the patient unable to understand the nature, scope and possible consequences of the study .

• Complicated with severe heart failure (class Ⅳ NYHA heart function) or unstable hemodynamics.

• Complicated with bronchial asthma, bronchiectasis or active tuberculosis；

• Complicated with obliterative bronchiolitis or diffuse pantothenic bronchiolitis，

• Complicated with pneumothorax, pleural effusion or pulmonary embolism.

• Complicated with neuromuscular disorder which affects the respiration.

• Complicated with tumors.

• Complicated with serious hepatic and renal diseases.

• Long periods of bed rest.

• Use of oral or parenteral corticosteroids before 1 months of Visit 1 .

• With immunodeficiency.

• Participating in other trials or allergic to the used medicine.